-
-
-
-
-
-
-
Merck (MRK) Acquisition of Acceleron Pharma Cleared by Antitrust Authorities in Germany and Austria
-
-
-
-
-
-
-
Merck Begins Tender Offer to Acquire Acceleron Pharma Inc.
-
-
-
-
-
-
-
Merck (MRK) to Acquire Acceleron Pharma (XLRN) for $180 Per Share in $11.5 Billion Deal
-
-
-
-
-
-
-
Bristol Myers Squibb Reports Second Quarter Financial Results for 2021
-
-
-
-
-
-
-
Acceleron Pharma (XLRN) Names New Board Chair
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

